Target intelligence / Profile preview

Stem-loop binding protein (SLBP)

Target
SLBP
Molecular classification
RNA-binding protein, mRNA-processing factor, Post-transcriptional regulator, Other (not a receptor, enzyme, transporter, or classical transcription factor)
01

Overview

Stem-loop binding protein (SLBP) is a key regulatory protein that binds with high specificity to the conserved stem-loop structure at the 3′ end of replication-dependent histone mRNAs[1][2][3][4][5]. Unlike most mRNAs, histone mRNAs lack polyadenylation and rely on SLBP for post-transcriptional processing, export from the nucleus, stability, and translation. SLBP participates in the cleavage of histone pre-mRNAs through interactions with the U7 snRNP complex, promoting efficient and timely histone gene expression during DNA replication. The RNA-binding domain of SLBP recognizes the overall shape of the stem-loop and specific base pairs, stabilizing mRNA structure and facilitating recruitment of processing factors. SLBP levels and activity are tightly regulated during the cell cycle and play a critical role in coupling histone synthesis to DNA replication in eukaryotic cells[1][2][3][4][5]. Abnormal SLBP function can impair cell proliferation and differentiation, and has been implicated experimentally in certain developmental and proliferative disorders[3][4].

Other names
Histone RNA hairpin-binding proteinHBPHistone stem-loop-binding proteinHairpin binding proteinHistone binding proteinStem-loop (histone) binding proteinStem-loop binding proteinSLBP
02

Mechanism of action

None established for drugs targeting SLBP

03

Biological functions

Histone mRNA 3′ end processingRegulation of histone mRNA stabilityRegulation of histone mRNA translationCoupling histone synthesis to DNA replicationPromotion and stabilization of U7 snRNP binding to histone pre-mRNAPost-transcriptional regulation of cell cycle-dependent histone gene expression
04

Disease associations

Cancer (linked to regulation of cell cycle via histone synthesis; defects may affect proliferation and differentiation)Developmental defects (e.g., eye development/reduced oocyte histone mRNA deposition in model organisms)Other (abnormal regulation may contribute to disease, but SLBP itself is not a common drug target)
05

Safety considerations

Not applicable for therapeutics directly targeting SLBP; however, altered SLBP function could potentially disrupt cell proliferation and differentiation
06

Interacting drugs

None currently known
07

Biomarkers

SLBP levels or histone mRNA processing defects have been experimentally used as markers of cell cycle or replication-dependent histone synthesisNot established as a clinical biomarker for patient selection or drug efficacy

Beyond the preview

Go deeper on Stem-loop binding protein (SLBP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stem-loop binding protein (SLBP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call